250 related articles for article (PubMed ID: 23326238)
21. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
22. Biological and clinical significance of epigenetic alterations in B-cell lymphomas.
Ennishi D
Int J Hematol; 2022 Dec; 116(6):821-827. PubMed ID: 36208393
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.
Jiang Y; Soong TD; Wang L; Melnick AM; Elemento O
PLoS One; 2012; 7(7):e40332. PubMed ID: 22808135
[TBL] [Abstract][Full Text] [Related]
24. Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.
Zhang YW; Zhang J; Li J; Zhu JF; Yang YL; Zhou LL; Hu ZL; Zhang F
Leuk Lymphoma; 2015; 56(8):2429-38. PubMed ID: 25487076
[TBL] [Abstract][Full Text] [Related]
25. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ
PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834
[TBL] [Abstract][Full Text] [Related]
27. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
Rinaldi A; Mensah AA; Kwee I; Forconi F; Orlandi EM; Lucioni M; Gattei V; Marasca R; Berger F; Cogliatti S; Cavalli F; Zucca E; Gaidano G; Rossi D; Bertoni F
Br J Haematol; 2013 Oct; 163(2):194-204. PubMed ID: 23961875
[TBL] [Abstract][Full Text] [Related]
28. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities.
Skinnider BF; Horsman DE; Dupuis B; Gascoyne RD
Hum Pathol; 1999 Jul; 30(7):803-8. PubMed ID: 10414499
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation profiling in human Huntington's disease brain.
De Souza RA; Islam SA; McEwen LM; Mathelier A; Hill A; Mah SM; Wasserman WW; Kobor MS; Leavitt BR
Hum Mol Genet; 2016 May; 25(10):2013-2030. PubMed ID: 26953320
[TBL] [Abstract][Full Text] [Related]
31. Follicular origin of a subset of CD5(+) diffuse large B-cell lymphomas.
Catherwood MA; Venkatraman L
Am J Clin Pathol; 2006 Jun; 125(6):954-5. PubMed ID: 16761357
[No Abstract] [Full Text] [Related]
32. Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.
Zhang YW; Xie HQ; Chen Y; Jiao B; Shen ZX; Chen SJ; Zhao WL
Int J Hematol; 2010 Oct; 92(3):439-44. PubMed ID: 20859709
[TBL] [Abstract][Full Text] [Related]
33. Insulator dysfunction and oncogene activation in IDH mutant gliomas.
Flavahan WA; Drier Y; Liau BB; Gillespie SM; Venteicher AS; Stemmer-Rachamimov AO; Suvà ML; Bernstein BE
Nature; 2016 Jan; 529(7584):110-4. PubMed ID: 26700815
[TBL] [Abstract][Full Text] [Related]
34. CTCF-dependent chromatin insulator is linked to epigenetic remodeling.
Ishihara K; Oshimura M; Nakao M
Mol Cell; 2006 Sep; 23(5):733-42. PubMed ID: 16949368
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
Ayala-Ortega E; Arzate-Mejía R; Pérez-Molina R; González-Buendía E; Meier K; Guerrero G; Recillas-Targa F
BMC Cancer; 2016 Mar; 16():226. PubMed ID: 26983574
[TBL] [Abstract][Full Text] [Related]
38. ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma.
Ushmorov A; Leithäuser F; Ritz O; Barth TF; Möller P; Wirth T
Leukemia; 2008 Oct; 22(10):1942-4. PubMed ID: 18368067
[No Abstract] [Full Text] [Related]
39. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin.
Kawakami T; Zhang C; Okada Y; Okamoto K
Oncogene; 2006 Jun; 25(23):3225-36. PubMed ID: 16434968
[TBL] [Abstract][Full Text] [Related]
40. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
